Albany International Corp. filed a Form 8-K with the SEC on August 31, 2026, disclosing that Chief Financial Officer Willard Station has commenced a medical leave of absence and that Sean Valashinas has been appointed acting principal financial officer effective the same date.

Key Highlights

  • CFO on medical leave: Willard Station, Albany International's Chief Financial Officer and principal financial officer, began a medical leave of absence effective August 31, 2026; the duration has not been determined.
  • Acting CFO appointed: Sean Valashinas, the Company's Controller and Chief Accounting Officer, was appointed acting principal financial officer by the Board of Directors, also effective August 31, 2026.
  • Dual role: Valashinas will serve as both acting principal financial officer and continue in his existing role as principal accounting officer.
  • Tenure at Albany International: Valashinas, age 55, has served as Controller and Chief Accounting Officer at the Company since June 9, 2025.
  • No compensation changes: According to the filing, there are no changes to Valashinas's compensation terms in connection with his appointment.
  • No related-party concerns: The filing states there are no familial relationships or related-party transactions requiring disclosure under Items 401(d) or 404(a) of Regulation S-K.

Albany International Discloses CFO Leave and Acting Appointment

According to the filing, Albany International Corp. (NYSE:AIN) announced on August 31, 2026, that Willard Station, the Company's Chief Financial Officer and principal financial officer, commenced a medical leave of absence effective immediately. The filing notes that during the leave, Mr. Station "will not perform the duties of Chief Financial Officer or principal financial officer," and that the duration of the leave has not been determined.

In connection with the leave, the Company's Board of Directors appointed Sean Valashinas to serve as acting principal financial officer, adding that role to his existing position as Controller and Chief Accounting Officer. The filing describes Valashinas's background as including prior service as Vice President, Accounting, Treasury, and Tax at Resonetics, which the filing characterizes as "a leading manufacturer in the medical device industry." Before that, according to the filing, he worked at Standex International Corporation, described as "a publicly traded global industrial manufacturing company," from 2007 to 2024, where he held the title of Vice President, Chief Accounting Officer and Assistant Treasurer. The filing further notes that Valashinas is a Certified Public Accountant holding an Accounting degree from the University of Scranton and an MBA from Boston University.

The filing states that no changes to Valashinas's compensation terms are being made as a result of the appointment. A press release dated August 31, 2026, was furnished as Exhibit 99.1. The filing specifies that the information furnished under Item 7.01, including the press release, "shall not be deemed 'filed' for any purpose" under Section 18 of the Securities Exchange Act of 1934.

What Was Disclosed

Albany International disclosed a medical leave of absence by CFO Willard Station and the Board's appointment of Controller and Chief Accounting Officer Sean Valashinas as acting principal financial officer, both effective August 31, 2026, with no compensation changes for Valashinas.